Medicine
Macitentan 10 mg tablet
Macitentan 10 mg tablet is a generic prescription medicine for oral use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° C to 25° C (68° F to 77° F). Excursions are permitted between 15°…
Key facts
- Active ingredient (INN)
- Macitentan
- Brand
- Sold under the generic name
- Strength
- 10 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 1 blister pack, 5 blister pack and 19 more
- Manufacturers
- Torrent PharmaceuticalsIndiaAlembic PharmaceuticalsIndiaLaurus LabsIndiaSun Pharmaceutical IndustriesIndiaZydus LifesciencesIndiaAurobindo PharmaIndiaNovugen PharmaANI PharmaceuticalsAmneal Pharmaceuticals NYApotex
- Origin register
- US FDA, United States
- Storage
- Store at 20° C to 25° C (68° F to 77° F). Excursions are permitted between 15° C and 30° C (59° F and 86° F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C02KX04 Macitentan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 August 2025
- Identifiers
- RxCUI 1442137DailyMed set ID 8de5c74f-b172-4485-a3f0-95e0172299d8, 226049ba-9c76-0798-6725-ee027a041820, 98b3309a-5012-42b5-b773-a38c2f52296c +11NDC 47335-070, 60505-4644, 62332-373 +11Application ANDA211123, ANDA211195, ANDA211128 +9
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 46708-373-30 | Alembic PharmaceuticalsIndia | 6 June 2026 |
| 30 tablet, film coated in 1 bottle | 62332-373-30 | Alembic PharmaceuticalsIndia | 6 June 2026 |
| 30 tablet, film coated in 1 bottle | 59651-147-30 | Aurobindo PharmaIndia | 8 June 2026 |
| 1 blister pack in 1 carton / 15 tablet, film coated in 1 blister pack | 42385-907-15 | Laurus LabsIndia | 15 May 2026 |
| 30 tablet, film coated in 1 bottle | 42385-907-30 | Laurus LabsIndia | 15 May 2026 |
| 5 blister pack in 1 carton / 3 tablet, film coated in 1 blister pack | 47335-070-15 | Sun Pharmaceutical IndustriesIndia | 6 June 2026 |
| 1 bottle in 1 carton / 30 tablet, film coated in 1 bottle | 47335-070-30 | Sun Pharmaceutical IndustriesIndia | 6 June 2026 |
| 500 tablet in 1 bottle | 13668-542-05 | Torrent PharmaceuticalsIndia | 1 June 2026 |
| 30 tablet in 1 bottle | 13668-542-30 | Torrent PharmaceuticalsIndia | 1 June 2026 |
| 90 tablet in 1 bottle | 13668-542-90 | Torrent PharmaceuticalsIndia | 1 June 2026 |
| 30 tablet, film coated in 1 bottle | 70710-1166-3 | Zydus LifesciencesIndia | 5 November 2025 |
| 5 blister pack in 1 carton / 3 tablet, film coated in 1 blister pack | 70710-1166-5 | Zydus LifesciencesIndia | 5 November 2025 |
| 1 bottle in 1 carton / 30 tablet, film coated in 1 bottle | 69238-1327-3 | Amneal Pharmaceuticals NY | 8 June 2026 |
| 30 tablet, film coated in 1 bottle | 70954-025-10 | ANI Pharmaceuticals | 1 October 2026 |
| 1 blister pack in 1 carton / 15 tablet, film coated in 1 blister pack | 70954-025-20 | ANI Pharmaceuticals | 1 October 2026 |
| 1 bottle in 1 carton / 30 tablet, film coated in 1 bottle | 60505-4644-3 | Apotex | 11 June 2026 |
| 30 tablet, film coated in 1 bottle, plastic | 0378-0606-93 | Mylan Pharmaceuticals | 8 June 2026 |
| 1 blister pack in 1 carton / 15 tablet, film coated in 1 blister pack | 82293-041-10 | Novugen Pharma | 5 June 2026 |
| 30 tablet, film coated in 1 bottle | 82293-041-20 | Novugen Pharma | 5 June 2026 |
| 100 tablet, film coated in 1 bottle | 82293-041-30 | Novugen Pharma | 5 June 2026 |
| 30 tablet, film coated in 1 bottle | 0781-8135-31 | Sandoz | 5 June 2026 |
| 30 tablet, film coated in 1 bottle | 0480-0915-56 | Teva Pharmaceuticals | 8 June 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Macitentan 10 mg tablet.
Clinical summary
Macitentan is an endothelin receptor antagonist. It is available as tablets for oral use. MedsAcross supplies Macitentan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MacitentanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- OPSUMIT prescribing information (Actelion Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Opsumit: European public assessment report (EPAR) · European Medicines Agency
- Macitentan Accord: European public assessment report (EPAR) · European Medicines Agency
Need Macitentan 10 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.